High Content Semaglutide Peptide Raw Material for Formulation Research
TDS 62 Inquiries
89030-95-5
Research Grade
99%
Guangdong
OEM
5mg/vial
2026-07-09
Tirzepatide,Retatrutide,Semaglutide,GHK-Cu
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceCopper Tripeptide is a tripeptide molecule rich in copper ions. Its sequence is GHK and it is widely present in human blood, saliva and urine. With age, the concentration of GHK gradually decreases, which is related to the decline of organ regeneration ability. Copper Tripeptide has strong antioxidant capacity, neutralizes free radicals, protects the skin from environmental damage, and with its unique copper ion affinity, it plays a role in promoting wound healing and activating skin regeneration.Certificates
-
TDS
Basic Info-
Product Name:
Copper tripeptide
Other Name:[N2-(N-Glycyl-L-histidyl)-L-lysinato(2-)]copper;Ghk-Cu/AHK-CU;Copper tripeptide (GHK-Cu);Prezatide copper,[N2-(N-Glycyl-L-histidyl)-L-lysinato(2-)]copper;tripeptide/GHK-Cu;Copper peptide, GHK-Cu, Copper tripeptide-1;GHK Copper;GHK.CU.HAC
CAS No.:89030-95-5
Molecular Formula:C14H21CuN6O4
InChIKeys:DDNUEECOCUBKBT-MIIMWFGWNA-L
Molecular Weight:400.91
Exact Mass:402.10800
EC Number:1308068-626-2
Color/Form:Light blue to blue
Categories:
Characteristics-
PSA:
186.03000
XLogP3:1.04530
Critical Temperature & Pressure:under inert gas (nitrogen or Argon) at 2–8 °C
Research-
Class:
GLP-1R agonist
Status:FDA-approved (Ozempic / Wegovy / Rybelsus)
Mechanism:Long-acting, selective glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to human GLP-1. Engineered for extended half-life (~1 week) via albumin binding (fatty acid acylation at Lys26) and resistance to DPP-4 degradation (Aib substitution at position 8). Promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces appetite via central nervous system GLP-1R activation.
Activity note:Potent, selective GLP-1R agonist. Reported binding affinity Ki = 0.38 ± 0.06 nM. Semaglutide is a human GLP-1 analog with structural modifications for albumin binding (C18 fatty diacid at Lys26) and enzymatic stability (Aib8 substitution).
Source:Lau J, et al. J Med Chem. 2015;58(18):7370-7380. Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002.DOI
Clinical Development:FDA:Ozempic, Wegovy, Rybelsus (approved 2017-12-05)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Literature:
NEJM: Wilding et al. (2021) — STEP-1; NEJM: Marso et al. (2016) — SUSTAIN-6; J Med Chem: Lau et al. (2015) — Discovery of Semaglutide; FDA: Ozempic (NDA 209637)
Disclaimer:Semaglutide is approved as a prescription medicine (Ozempic, Wegovy, Rybelsus) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,Semaglutide,GHK-Cu
-
Location:
RM 701, UNIT 108, 7/F, TWR B NEW MANDARIN PLAZA 14 SCIENCE MUSEUM RD TSIM SHA TSUI HONG KONG
-
Year of Establishment:
2026
-
-
Inquiry History62 Inquiries
Country Product Purchase Quantity Date Posted
Malaysia
Peptide GHK-Cu Copper Tripeptide-1 Powder CAS 89030-95-5
10 MG Apr 24, 2025
United States
GHK-Cu
20 MG Aug 12, 2026
Thailand
Copper Tripeptide-1
2 G Aug 3, 2026
United States
GHK-Cu
30 MG Aug 3, 2026
Philippines
GHK CU+KPV
10 PCS Jul 19, 2026
United States
Copper Tripeptide
10 MG Jul 14, 2026
United States
Klow
1 MT Jun 27, 2026
India
Copper Tripeptide-1GHK-Cu (CAS 89030-95-5)
5 KG Jun 22, 2026
Germany
Copper Tripeptide-1 (GHK-Cu)
20 G Jun 20, 2026
United States
GHK cu
1 MT May 19, 2026
China
GHK Cu
10000 Apr 21, 2026
China
GHK CU
500 MT Apr 14, 2026
Brazil
Tripeptídeo de cobre Ghk-Cu
100 MG Mar 25, 2026
Brazil
Ghk cu
1 KG Mar 18, 2026
United States
Ghk cu
1 MG Mar 6, 2026
Philippines
Copper Peptide 99% Blue powder
25 PCS Feb 21, 2026
United States
Ghk cu
10 MG Feb 12, 2026
Australia
GHKU
20 MT Jan 30, 2026
United States
GHK-Cu
1 G Jul 14, 2025
Malaysia
blue copper peptide GHK-Cu 98% Copper Tripeptide-1
10 MG Apr 24, 2025 Post an enquiry for this product
- Hot Searches
- ethylene glycol sds
- sodium lignosulfonate suppliers
- methyl acrylate sds
- active pharmaceutical ingredients bestellen
- sulfanilamide powder
- buy masteron
- research chems for sale
- capryloyl glycine market
- na 931 peptide for sale
- sulphonated naphthalene formaldehyde price
- potassium cyanide buy
- methylamine price per gallon